Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
Aim: to evaluate features of intrahepatic cholestasis (IHC) pathogenesis in non-alcoholic fatty liver disease (NAFLD), as well as role of ademetionine in treatment of this condition.Key statements. NAFLD is the most frequent chronic diffuse liver disease. Increase in proportion of people with excess...
Saved in:
Main Author: | Ye. N. Shirokova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2023-08-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/830 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cholestasis in Chronic Liver Disease and the Role of Ademetionine in its Treatment (Literature Review and Expert Panel Resolution)
by: K. L. Raikhelson, et al.
Published: (2024-10-01) -
Association between ABCB4 variants and intrahepatic cholestasis of pregnancy
by: Dekun Zhang, et al.
Published: (2025-01-01) -
Role of aspartate aminotransferase to platelet ratioin prediction of intrahepatic cholestasis of pregnancy
by: Nizamettin Bozbay, et al.
Published: (2024-12-01) -
Risk factors and machine learning prediction models for intrahepatic cholestasis of pregnancy
by: Yingchun Ren, et al.
Published: (2025-01-01) -
Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)